This inventor holds 1 USPTO granted patent. Top assignee: Gene Shears Pty. Limited. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Mark J Young - Innovator in Nucleic Acid Technology
Introduction
Mark J Young is a notable inventor based in West Lafayette, Indiana, who has made significant contributions to the field of nucleic acid technology. His innovative work focuses on developing methods to control viral pathogens, which has important implications for both agriculture and medicine.
Latest Patents
Mark J Young holds a patent for "Ribozyme nucleic acids and methods of use thereof for controlling viral pathogens." This invention consists of a non-naturally occurring nucleic acid molecule capable of blocking or interfering with a replicative intermediate of a virus, a virusoid, or a viroid. The nucleic acid molecule may contain a ribozyme or a plurality of ribozymes, and it can also be an antisense nucleic acid molecule. The ribozyme may take various forms, including hairpin ribozymes, hammerhead ribozymes, RNAase P ribozymes, minizymes, or other catalytic RNA molecules. This technology has the potential to control infections caused by a wide range of pathogenic infectious agents in both plants and animals.
Career Highlights
Mark J Young is associated with Gene Shears Pty. Limited, where he continues to advance his research and development efforts. His work has garnered attention for its innovative approach to addressing viral infections, showcasing his commitment to scientific advancement and public health.
Collaborations
Mark has collaborated with notable colleagues, including David G Atkins and Wayne Lyle Gerlach, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Mark J Young's contributions to nucleic acid technology exemplify the impact of innovative thinking in addressing complex biological challenges. His work not only enhances our understanding of viral pathogens but also paves the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile